January 17, 2023 Experience China Resources Beer RMB12.3 billion acquisition of Jinsha Winery We advised China Resources Beer on the acquisition of a controlling interest in Jinsha Winery
January 12, 2023 Experience Mongolian Mining acquisition of 50% of Erdene Mongol We are advising MMC on the acquisition
January 11, 2023 Experience Sirio Pharma acquisition of a majority stake of Best Formulations We advised Sirio Pharma on the acquisition
November 17, 2022 Experience KOITO $100 million investment in Cepton We are advising KOITO on its investment in convertible preferred stock
September 8, 2022 Experience Tencent €300 million investment in Ubisoft We are advising Tencent on the transaction
August 19, 2022 Experience Esco Aster spinoff transactions We are advising Esco Lifesciences on the spinoff
August 11, 2022 Experience InSilico Medicine $35 million Series D2 financing We are advising InSilico Medicine on the financing
August 3, 2022 Experience Taibang Biologic Group $300 million equity raising We are advising Taibang Biologic Group in connection with its equity raising by a group of investors
June 29, 2022 Experience Tencent renewed strategic cooperation with JD.com We are advising Tencent on the renewal of the strategic cooperation agreement and purchase of ordinary shares of JD.com
June 7, 2022 Experience InSilico Medicine $60 million Series D financing We are advising InSilico Medicine in connection with its $60 million Series D financing